Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
SRXH · NYSE · United States · Beverages
In shortSRX Global Inc. is loss-making, burns cash and holds more cash than debt, with revenue shrinking (−88.0% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -174.6% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -688.8% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -410.4% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -2213.9% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 2.29× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.00× | 100/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -18.16× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -14.39 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -124.6% | 0/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 0 of 5 | 0/100 |
Weight in the score: 20%
| Profitable years (last 5) | 1 of 5 | 20/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 94.2% | 0/100 |
| Operating margin volatility | 83.7% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -46.5% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY25 |
|---|---|---|---|---|---|
| Revenue | 16 | 43 | 46 | 55 | 6.5 |
| Cost of revenue | 9.7 | 26 | 31 | 39 | 5 |
| Gross profit | 5.9 | 16 | 15 | 15 | 1.5 |
| Research & development | – | 0.1 | 0.5 | 0.5 | – |
| Selling, general & admin | – | 34 | 29 | 35 | 13 |
| Operating income | (36) | (27) | (17) | (39) | (11) |
| Interest expense | 0.7 | 9.2 | – | 0.6 | 0.6 |
| Pre-tax income | – | (59) | 3.4 | (39) | (8.6) |
| Income tax | 0 | 0 | 0 | (0) | – |
| Net income | (184) | (59) | 3.4 | (39) | (45) |
| Diluted EPS | −$5.55 | −$7.26 | $0.14 | −$58.93 | −$2.13 |
| Diluted shares (millions) | 33 | 8.2 | 22 | 0.7 | 21 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
−14.39 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
2/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 13, 2026